Status:
COMPLETED
Efficacy and Safety of Oral Versus Intravenous Ibuprofen for PDA Treatment in ELBW Infants
Lead Sponsor:
Zekai Tahir Burak Women's Health Research and Education Hospital
Conditions:
Patent Ductus Arteriosus
Eligibility:
All Genders
1-7 years
Phase:
NA
Brief Summary
To determine whether oral or intravenous ibuprofen has a better or same efficacy and tolerance in closure of patent ductus arteriosis in extremely-low-birth-weight preterm infants.
Detailed Description
To determine whether oral or intravenous ibuprofen has a better or same efficacy and tolerance in closure of patent ductus arteriosis in extremely-low-birth-weight preterm infants.Seventy ELBW preterm...
Eligibility Criteria
Inclusion
- Birth weight below 1000 gram
- Diagnosed patent ductus arteriosis by Echocardiographic examination
Exclusion
- Accompanied other congenital cardiac anomalies
- Severe thrombocytopenia \< 60.000
- Severe intracranial bleeding (Grade 3-4)
- Intestinal abnormality and necrotising enterocolitis
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2011
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT01261117
Start Date
January 1 2009
End Date
June 1 2011
Last Update
August 9 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zekai Tahir Burak Maternity Teaching Hospital
Ankara, Turkey (Türkiye), 06600